|
|
||||||||
Articles |
Service de Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine and Université de Montréal, Montréal, QC, Canada.
a Address correspondence to this author at: Service de génétique médicale, Hôpital Ste-Justine, 3175 Côte Ste-Catherine, Montréal, QC, Canada H3T 1C5. Fax 514-345-4766; e-mail lamberma{at}ere.umontreal.ca
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In the present paper, we propose an alternative method of analyzing results that takes advantage of all amino acid values. The distribution of amino acid concentrations is presented graphically from birth to 18 years of age, showing the 10th, 50th, and 90th quantile curves. Thus, the amino acid values of a patient with a particular metabolic disease can be easily compared from infancy to adulthood with those of the control population of the appropriate age.
| Materials and Methods |
|---|
|
|
|---|
|
All plasma samples were analyzed fresh or stored at -80 °C until assayed. Before analysis, 2-aminoethyl cysteine hydrochloride (Calbiochem) was added to plasma and used as an internal calibrator. Then, plasma samples were deproteinized according to Mondino et al. (9) with sulfosalicylic acid (ICN Biomedicals) and brought to pH 2.2 with LiOH (Baker Chemical). After filtration, samples were ready for analysis.
amino acid analysis
Analysis was performed with the Beckman System 7300 High
Performance Amino Acid Analyzer, according to manufacturer's
specifications. Briefly, this analyzer utilizes cation-exchange
chromatography with a step buffer elution and with ninhydrin detection.
Absorbance of amino acidninhydrin complexes is detected at 570 nm for
primary amino groups and at 440 nm for proline and hydroxyproline.
Amino acid concentration is automatically calculated on the basis of
both the calibrators and the internal calibrator.
Buffers designed for the Beckman System 7300 Amino Acid Analyzer, the amino acid calibrators, and ninhydrin were all purchased from Beckman Instruments. Tryptophan, glutamine, asparagine (Calbiochem), and 5-aminolevulinic acid (Sigma) were added to complete the amino acid calibrator mix.
cvs
To establish the mean CV for the individual amino acid
concentrations obtained with the Beckman System 7300 High Performance
Amino Acid Analyzer, six blood samples were used, and each sample was
analyzed on five different occasions. Conservation of the deproteinized
sample was at -80 °C. The mean CVs were calculated as follows: For
every amino acid, the CVs were calculated for each blood sample; the
mean CV was then computed for each amino acid.
statistical methods
Parametric statistical analyses were performed with SAS
statistical software [release 6.09 (1989), SAS Institute].
Nonparametric analyses were done with the Mathematica program [release
2.2 (1988), Wolfram Research]
First, a descriptive univariate analysis was undertaken to assess the quality of the data, and to identify missing data, lack of continuity, or nonnormal distribution characteristics. Hence t-tests were performed on all amino acid concentrations, verifying for sex difference. Significant statistical differences were obtained only for isoleucine (P = 0.01) and for lysine (P = 0.03) when data from the 148 control children were analyzed. However, no significant statistical difference for these two amino acids was observed (isoleucine, P = 0.4; lysine, P = 0.08) when data from the 114 children over age 1 year were analyzed. Therefore, sex was not taken into consideration for subsequent analyses.
Next, a regression analysis was performed on each amino acid concentration to determine its polynomial relation to age (10). Where the assumptions needed to apply regression were met, the 10th and 90th quantiles were calculated. Then, the two-sided 90% confidence bands for the 10th and 90th quantile curves were computed (10). Because they would have been almost superimposed on the 50th quantile curve, the two-sided confidence bands were not calculated for the median curve.
Finally, when the assumptions needed to apply regression failed (alanine, arginine, asparagine, aspartic acid, citrulline, cystine, glutamic acid, isoleucine, leucine, methionine, ornithine, phenylalanine, proline, serine, taurine, threonine, tyrosine, and valine), parametric methods became inappropriate and we turned to kernel estimators to calculate the 10th, 50th, and 90th quantiles. Again, the two-sided 90% confidence bands were obtained (11).
Both methods, as expected by definition, led to 10% of amino acid concentrations being higher than the 90th quantile value, and to 10% of concentrations being lower than the 10th quantile value.
| Results and Discussion |
|---|
|
|
|---|
|
Values of amino acids tend to vary up to 18 years of age (Figs. 1
to 5). The concentrations
rangefrom undetectable to 1000 µmol/L and each amino acid possesses its
own maximum values. For convenience of illustration, we have used four
different scales with respect to the maximum concentration shown by
each amino acid (scale 1: maximum <100 µmol/L; 2: <250 µmol/L; 3:
<500 µmol/L; and 4: <1000 µmol/L). A unique pattern of
distribution is demonstrated for each amino acid. However, we can
identify common tendencies. As shown in Fig. 1a
i, concentrations of
this group of amino acids tend to decrease during the first years of
life, then increase steadily up to 18 years of age. Alanine (a),
arginine (b), asparagine (c), methionine (d), ornithine (e),
phenylalanine (f), proline (g), threonine (h), and tyrosine (i) belong
to this first group. Two amino acids, serine and taurine, show an
initial reduction in their concentrations followed by stable
concentrations (Figs. 2
a and 2b).
Aspartic acid (Fig. 3
a) and glutamic acid (Fig. 3b
) demonstrate decreasing values
throughout the studied period. Figs. 4
and
5 display amino acids with no initial decrease in their
concentrations. Citrulline (Fig. 4
) shows a modest two-step increment:
The first increase occurs from 0 to 3 years of age, and the second from
13 to 15 years. The last group includes nine amino acids showing
steadily increasing concentrations throughout infancy, childhood, and
adolescence: cystine, glutamine, glycine, histidine, isoleucine,
leucine, lysine, tryptophan, and valine (Figs. 5a
to 5i). Table 3
gives the numerical values for the 10th, 50th, and 90th
quantiles of plasma amino acid concentrations at four different ages: 6
months, 2 years, 6 years, and 16 years.
|
|
|
|
|
|
The potential for comparison of these results with others is limited
because previous reports did not take into account the 10th, 50th, and
90th quantile values, and amino acid reference values were usually
presented as mean concentrations with their individual SDs for the
selected population. Scott et al. (13) studied amino acid
concentrations in infants at five different ages: 11 days, 21 days, 7
weeks, 11 weeks, and 15 weeks. The age distribution from 0 to 4 months
that can be estimated from the study is consistent with our results
except for alanine, asparagine, glycine, and lysine. In the Scott
study, alanine and asparagine showed a continuous increase in
concentrations, whereas we observed a decrease up to age 2 years for
asparagine (Fig. 1c
) and up to age 3 years for alanine (Fig. 1a
). Scott
et al. found a decrease in concentration for glycine and lysine
(13), whereas we observed an increase in concentration
(Fig. 5c
and g). However, Janas et al. (5) measured amino
acid concentrations in infants of three different ages: 2 weeks, 4
weeks, and 8 weeks. In comparison with our results, discordant profiles
are only seen for arginine and cystine: arginine showed a slight
increase, whereas we observed a decrease (Fig. 1d
), and cystine showed
a slight decrease, whereas we observed an increase in concentration
(Fig. 5a
). Finally, a third report compared amino acid concentrations
at ages 8 and 16 years (7). The conclusions reached in
that study were similar to ours except for phenylalanine, which showed
a decrease in concentration where we found an increase (Fig. 1f
). Thus,
our results compare adequately with previous reports.
Many analytes, including plasma amino acids, show an age-related distribution of their concentrations. This underlines the importance of using appropriate reference values when working with a pediatric population. Quantile curves that illustrate the age-dependent variation of the median (50th quantile) and the extremes (10th and 90th quantiles) of plasma amino acid concentrations should be a useful tool for the follow-up of patients with disorders of amino acid metabolism. Variations in amino acid concentrations according to age should be considered by clinical chemists studying amino acids in children.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
The following articles in journals at HighWire Press have cited this article:
![]() |
S. Verbruggen, J. Sy, W. E. Gordon, J. Hsu, M. Wu, S. Chacko, D. Zurakowski, D. Burrin, and L. Castillo Ontogeny of methionine utilization and splanchnic uptake in critically ill children Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1046 - E1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A van Waardenburg, C. T de Betue, Y. C Luiking, M. Engel, and N. E Deutz Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1438 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A.B. Smith, J. A. Canter, K. G. Christian, D. C. Drinkwater, F. G. Scholl, B. W. Christman, G. D. Rice, F. E. Barr, and M. L. Summar Nitric oxide precursors and congenital heart surgery: A randomized controlled trial of oral citrulline J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 58 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, L. Pickell, Y. Liu, Q. Wu, J. S Cohn, and R. Rozen Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice Am. J. Clinical Nutrition, July 1, 2005; 82(1): 188 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Summar, J. V. Gainer, M. Pretorius, H. Malave, S. Harris, L. D. Hall, A. Weisberg, D. E. Vaughan, B. W. Christman, and N. J. Brown Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function Hypertension, February 1, 2004; 43(2): 186 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Pearson, S. Dawling, W. F. Walsh, J. L. Haines, B. W. Christman, A. Bazyk, N. Scott, and M. L. Summar Neonatal Pulmonary Hypertension- Urea-Cycle Intermediates, Nitric Oxide Production, and Carbamoyl-Phosphate Synthetase Function N. Engl. J. Med., June 14, 2001; 344(24): 1832 - 1838. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |